Roivant Sciences Ltd (ROIV): Congress and insider trades
Who in Congress and inside the company traded ROIV, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Roivant Sciences Ltd (ROIV) is a listed stock on NASDAQ.
- Insiders filed 0 open market buys worth $0 and 29 sells worth $244M, the latest filed 2026-09-10 (10 September 2026).
- Data as of 2026-09-29 (29 September 2026).
Insider trades in ROIV
as of 2026-09-10| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 10 Sep 2026 | Fitzgerald Meghan | sell | 20,000 | $39.90 | $798K | n/a |
| 1 Sep 2026 | Venker Eric | sell | 200,000 | $35.77 | $7.2M | n/a |
| 21 Aug 2026 | Sukhatme Mayukh | sell | 172,899 | $37.17 | $6.4M | n/a |
| 21 Aug 2026 | Sukhatme Mayukh | sell | 144,756 | $36.48 | $5.3M | n/a |
| 21 Aug 2026 | Sukhatme Mayukh | sell | 17,519 | $37.30 | $653K | n/a |
| 18 Aug 2026 | Sukhatme Mayukh | sell | 243,177 | $36.23 | $8.8M | n/a |
| 18 Aug 2026 | Sukhatme Mayukh | sell | 284,707 | $36.25 | $10M | n/a |
| 18 Aug 2026 | Sukhatme Mayukh | sell | 136,942 | $36.73 | $5.0M | n/a |
| 29 Jul 2026 | Venker Eric | sell | 200,000 | $34.95 | $7.0M | n/a |
| 2 Jul 2026 | Fitzgerald Meghan | sell | 10,000 | $34.90 | $349K | n/a |
| 1 Jul 2026 | Epperly Melissa B, | sell | 17,750 | $34.38 | $610K | n/a |
| 30 Jun 2026 | Gold Daniel Allen | sell | 800,000 | $34.55 | $28M | n/a |
| 30 Jun 2026 | MANCHESTER KEITH S | sell | 200,000 | $35.45 | $7.1M | n/a |
| 30 Jun 2026 | Gold Daniel Allen | sell | 12,380 | $35.28 | $437K | n/a |
| 30 Jun 2026 | QVT Financial LP | sell | 12,380 | $35.28 | $437K | n/a |
| 30 Jun 2026 | Gold Daniel Allen | sell | 625,783 | $34.00 | $21M | n/a |
| 30 Jun 2026 | QVT Financial LP | sell | 800,000 | $34.55 | $28M | n/a |
| 30 Jun 2026 | MANCHESTER KEITH S | sell | 800,000 | $34.55 | $28M | n/a |
| 30 Jun 2026 | MANCHESTER KEITH S | sell | 12,380 | $35.28 | $437K | n/a |
| 30 Jun 2026 | QVT Financial LP | sell | 625,783 | $34.00 | $21M | n/a |
| 30 Jun 2026 | MANCHESTER KEITH S | sell | 625,783 | $34.00 | $21M | n/a |
| 26 Jun 2026 | Venker Eric | sell | 200,000 | $33.16 | $6.6M | n/a |
| 22 May 2026 | Venker Eric | sell | 200,000 | $30.27 | $6.1M | n/a |
| 22 Apr 2026 | Venker Eric | sell | 200,000 | $29.59 | $5.9M | n/a |
| 20 Apr 2026 | Gline Matthew | sell | 289,774 | $29.16 | $8.4M | n/a |
| 10 Apr 2026 | Humes Jennifer | sell | 13,538 | $28.37 | $384K | n/a |
| 30 Mar 2026 | Fitzgerald Meghan | sell | 70,000 | $27.45 | $1.9M | n/a |
| 19 Mar 2026 | Venker Eric | sell | 200,000 | $28.24 | $5.6M | n/a |
| 18 Mar 2026 | Epperly Melissa B, | sell | 41,861 | $28.68 | $1.2M | n/a |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought ROIV?
0 Congress buys by 0 members and 0 insider buys are on file. The tables on this page list every one.
Did buying ROIV after a disclosure beat the market?
No disclosed buy of this stock has matured 90 days yet. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.